1 completed, 1 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Unknown 1 |
Follow Malignant Ovarian Brenner Tumor: new trials by email Literature Review of Malignant Ovarian Brenner Tumor trials Research Report on Malignant Ovarian Brenner Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Behavioral Dietary Intervention, Compliance Monitoring, Counseling - Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma | Phase 3 | Unknown | Gynecologic Oncology Group | 1070 | 2012-06-18 | 2018-02-19 |
| Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Bevacizumab, Carboplatin, Cisplatin - Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma | Phase 3 | Completed | National Cancer Institute (NCI) | 1560 | 2009-08-11 | 2026-06-02 |
Brenner Tumor (2) · Fallopian Tube Neoplasms (1)
Adnexal Diseases (2) · Endocrine System Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Genital Neoplasms, Female (2) · Gonadal Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Connective Tissue (2) · Neoplasms, Connective and Soft Tissue (2) · Neoplasms, Fibroepithelial (2) · Neoplasms, Fibrous Tissue (2) · Neoplasms, Glandular and Epithelial (2)
1,2-diaminocyclohexaneplatinum II citrate (1) · Bevacizumab (1) · Carboplatin (1) · Cisplatin (1) · Counseling (1) · Disulfides (1) · Early Intervention, Educational (1) · Educational Status (1) · Immunoglobulin G (1) · Methods (1) · Paclitaxel (1) · Platinum (1) · Taxes (1)
Gynecologic Oncology Group (1) · National Cancer Institute (NCI) (1)
United States (2)
David Alberts (1) · Joan L Walker (1)
PMID 27394382, PMID 31002578, PMID 36608382
U10CA027469 (1), U10CA101165 (1), U10CA180830 (1), U10CA180868 (1), UG1CA189867 (1)